WI
WINVW
WinVest Acquisition Corp.
No data for this timeframe.
Vol
Inst. Holders1 funds
Inst. Value$104.00
SEC Reports4
Recent Activity
Jun 1, 2026
SEC
WinVest Acquisition Corp. filed a Form 425 (8-K) disclosing an amended business combination agreement with Embed Financi
425 — Impact 4/10
Jun 1, 2026
SEC
WinVest Acquisition Corp. (WINVW) filed an 8-K reporting an amendment to its business combination agreement with Embed F
8-K — Impact 4/10
May 12, 2026
SEC
WinVest Acquisition Corp. drew down the third $30,000 tranche of an existing $180,000 unsecured promissory note from its
8-K — Impact 3/10
Latest Reports
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| UBS Group AG | $104.00 | — |
1 institutional holders with $104.00 total value (7,400 shares) as of 2024-Q4. Top holders: UBS.
Top Institutional Holders — 2024-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | UBS Group AG | 7,400 | $104.00 | 100.0% | — |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
4 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 4 neutral. Avg impact: 3.5/10.
NEUTRAL
425
4/10
WinVest Acquisition Corp. filed a Form 425 (8-K) disclosing an amended business combination agreemen
Jun 1, 2026
NEUTRAL
8-K
4/10
WinVest Acquisition Corp. (WINVW) filed an 8-K reporting an amendment to its business combination ag
Jun 1, 2026
NEUTRAL
8-K
3/10
WinVest Acquisition Corp. drew down the third $30,000 tranche of an existing $180,000 unsecured prom
May 12, 2026
NEUTRAL
8-K
3/10
WinVest Acquisition Corp. drew down $30,000 on an existing unsecured promissory note from its sponso
Apr 15, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.